Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition
1Department of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University School of Medicine, St Louis, MO, 63104, USA.
Abstract:
Defining the suppressive mechanisms used by regulatory T (Treg) cells is critical for the development of effective strategies for treating tumors and chronic infections. The molecular processes that occur in responder T cells that are suppressed by Treg cells are unclear. Here we show that human Treg cells initiate DNA damage in effector T cells caused by metabolic competition during cross-talk, resulting in senescence and functional changes that are molecularly distinct from anergy and exhaustion. ERK1/2 and p38 signaling cooperate with STAT1 and STAT3 to control Treg-induced effector T-cell senescence. Human Treg-induced T-cell senescence can be prevented via inhibition of the DNA damage response and/or STAT signaling in T-cell adoptive transfer mouse models. These studies identify molecular mechanisms of human Treg cell suppression and indicate that targeting Treg-induced T-cell senescence is a checkpoint for immunotherapy against cancer and other diseases associated with Treg cells.
Insights
Regulatory T (Treg) cells cause DNA damage in effector T cells through metabolic competition, leading to senescence. This process can be blocked by inhibiting DNA damage response or STAT signaling, offering new immunotherapy targets.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- Regulatory T (Treg) cells suppress immune responses, crucial for managing tumors and infections.
- Mechanisms of Treg-mediated suppression of effector T cells remain incompletely understood.
- Identifying these mechanisms is key for developing novel immunotherapies.
Purpose of the Study:
- To elucidate the molecular mechanisms by which human Treg cells suppress effector T cells.
- To investigate the role of DNA damage and senescence in Treg-mediated suppression.
- To identify potential therapeutic targets for Treg-associated diseases.
Main Methods:
- Investigated molecular processes in effector T cells suppressed by human Treg cells.
- Utilized cross-talk assays and metabolic competition studies.
- Employed mouse models with T-cell adoptive transfer to test interventions.
Main Results:
- Human Treg cells induce DNA damage in effector T cells via metabolic competition, causing senescence.
- This senescence is distinct from anergy and exhaustion.
- ERK1/2, p38, STAT1, and STAT3 signaling pathways are critical for Treg-induced effector T-cell senescence.
- Inhibition of DNA damage response and/or STAT signaling prevented Treg-induced T-cell senescence in vivo.
Conclusions:
- Human Treg cells suppress effector T cells by inducing DNA damage and senescence.
- Targeting Treg-induced T-cell senescence presents a novel checkpoint for cancer immunotherapy.
- Understanding these pathways can inform treatments for diseases involving Treg cells.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Competition
Cis-regulatory Sequences
Overview of DNA Repair
Chemically...


